Since retatrutide is a subcutaneous injection, food does not affect absorption
These medications are generally recommended for: People with type 2 diabetes who struggle to control their blood sugar Individuals who are overweight or obese with weight-related health risks Patients who haven't responded well to other diabetes medications However, GLP-1 agonists are not suitable for everyone
In pharmacological research, higher dosing does not necessarily improve outcomes, particularly with high-potency peptide therapies
Activation of these receptors helps coordinate satiety signaling, gastric motility, and overall energy homeostasis
Meet the experts: Kunal Shah, M.D., an assistant professor in the division of endocrinology at the Rutgers Robert Wood Johnson Medical Center
Weight regain is common once the medication is discontinued, indicating people may need to remain on these drugs to maintain weight loss